Mirum Pharmaceuticals (MIRM) Work In Process (2021 - 2026)

Mirum Pharmaceuticals has reported Work In Process for 6 years, with the latest figure at $19.5 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 23.21% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 23.21% YoY), and the FY2025 full-year result was $18.5 million, up 14.82% from the prior year.
• Work In Process for Q1 2026 stood at $19.5 million, up from $18.5 million in the prior quarter.
• The five-year high for Work In Process was $19.5 million in Q1 2026, with the low at $553000.0 in Q1 2022.
• Average Work In Process over 5 years is $11.3 million, with a median of $10.8 million recorded in 2024.
• Year-over-year, Work In Process soared 1072.51% in 2023 and increased 14.82% in 2025.
• Tracing MIRM's Work In Process over 5 years: stood at $5.4 million in 2022, then surged by 84.51% to $9.9 million in 2023, then surged by 62.96% to $16.1 million in 2024, then grew by 14.82% to $18.5 million in 2025, then increased by 5.49% to $19.5 million in 2026.
• The last three Work In Process figures came in at $19.5 million (Q1 2026), $18.5 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.

Peer Comparison